Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 94, 82-86
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Evaluation of perampanel in patients with intellectual disability and epilepsyEpilepsy & Behavior, 2017
- Tolerability and efficacy of perampanel in children with refractory epilepsyDevelopmental Medicine & Child Neurology, 2016
- Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter studyEpilepsy Research, 2016
- Perampanel Serum Concentrations in Adults With EpilepsyTherapeutic Drug Monitoring, 2016
- Zonisamide: Pharmacokinetics, Efficacy, and Adverse Events in Children with EpilepsyNeuropediatrics, 2014
- Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizuresEpilepsia, 2013
- PerampanelCNS Drugs, 2012
- Adjunctive perampanel for refractory partial-onset seizuresNeurology, 2012
- Randomized phase III study 306Neurology, 2012
- Serum Concentrations of Rufinamide in Children and Adults With Epilepsy: The Influence of Dose, Age, and ComedicationTherapeutic Drug Monitoring, 2011